Another Blood Pressure Medication Recalled Over Trace Amounts Of Cancer-Causing Chemical

Henrietta Brewer
January 6, 2019

A significant pharmaceutical company is reportedly recalling the medication to overcome blood pressure over the concerns that the medicinal tablets may be containing the trace amounts of a compound or an element that has the probability of causing cancer.

This week Aurobindo Pharma USA announced a voluntary recall of 78 lots of valsartan tablets, and Torrent Pharmaceuticals expanded its voluntary recall of losartan potassium tablets to a total of 10 lots.

"Because of the risk associated with suddenly stopping high blood pressure medication, people are advised not to stop any treatments without consulting their doctor or pharmacist".

If your medication has been affected by the recall, contact a health care professional for further information.

In October previous year, the FDA halted imports of drug ingredients or medicines containing ingredients produced at a factory of a Chinese bulk manufacturer of valsartan, Zhejiang Huahai Pharmaceuticals.

The products subject to recall are listed below and packaged in bottles.

Aurobindo Pharma recently stated that according to an IARC (International Agency for Research on Cancer) classification, the impurity NDEA discovered in the finished drug is a naturally-occurring substance found in drinking water, industrial processes, air pollution, and certain foods. The company says it has not received "any reports" that its drugs have actually caused cancer in any patients, but it's issuing the recall to make sure that doesn't happen in the future. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products. The recalled medication was distributed nationwide to distributors, repackagers, and retail customers. The agency stresses that not all valsartan and related products are under recall, only specific lots. Instructions for returning recalled products are given in the recall letter. No adverse symptoms have been reported until now. You can check out the full list of products along with their lot numbers on the FDA's recall page.

Other reports by iNewsToday